US-based biotechnology company Inceptor Bio has dosed the first subject in the investigator-initiated trial of its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback